Aberdeen Group’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.55M Buy
113,843
+84,917
+294% +$6.7M 0.01% 614
2025
Q4
$2.29M Sell
28,926
-58,998
-67% -$4.44M ﹤0.01% 768
2025
Q3
$5.75M Sell
87,924
-318,770
-78% -$15.6M 0.01% 685
2025
Q2
$16.2M Sell
406,694
-39,503
-9% -$1.29M 0.03% 474
2025
Q1
$13.5M Buy
446,197
+44,696
+11% +$1.46M 0.03% 492
2024
Q4
$14M Buy
401,501
+98,227
+32% +$3.67M 0.03% 446
2024
Q3
$12.1M Buy
303,274
+56,357
+23% +$2.62M 0.02% 485
2024
Q2
$11.8M Buy
246,917
+27,496
+13% +$1.13M 0.02% 482
2024
Q1
$9.51M Buy
219,421
+83,002
+61% +$3.96M 0.02% 558
2023
Q4
$6.9M Buy
+136,419
New +$6.53M 0.02% 619
2021
Q2
Sell
-5,197
Closed -$234K 1026
2021
Q1
$234K Buy
5,197
+405
+8% +$22.6K ﹤0.01% 971
2020
Q4
$271K Buy
4,792
+543
+13% +$27.1K ﹤0.01% 931
2020
Q3
$202K Sell
4,249
-3,620
-46% -$201K ﹤0.01% 922
2020
Q2
$464K Buy
7,869
+18
+0.2% +$1K ﹤0.01% 866
2020
Q1
$372K Buy
7,851
+213
+3% +$11.9K ﹤0.01% 865
2019
Q4
$461K Buy
7,638
+132
+2% +$7.87K ﹤0.01% 887
2019
Q3
$450K Sell
7,506
-20,294
-73% -$1.32M ﹤0.01% 865
2019
Q2
$1.79M Buy
+27,800
New +$1.97M ﹤0.01% 758

Other funds holding IONS